|
Volumn 86, Issue 8, 2008, Pages 648-649
|
Access to medicines versus access to treatment: The case of type 1 diabetes
|
Author keywords
[No Author keywords available]
|
Indexed keywords
INSULIN;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
DIABETES;
DISEASE TREATMENT;
HEALTH POLICY;
HUMAN IMMUNODEFICIENCY VIRUS;
PUBLIC ACCESS;
PUBLIC HEALTH;
WORLD HEALTH ORGANIZATION;
DRUG COST;
DRUG INDUSTRY;
HEALTH CARE ACCESS;
HEALTH CARE COST;
HEALTH CARE FACILITIES AND SERVICES;
HEALTH CARE PERSONNEL;
HEALTH CARE POLICY;
HEALTH CARE SYSTEM;
HEALTH SERVICE;
INSULIN DEPENDENT DIABETES MELLITUS;
ORGANIZATION AND MANAGEMENT;
PATIENT CARE;
SHORT SURVEY;
AFRICA;
CHRONIC DISEASE;
DEVELOPING COUNTRIES;
DIABETES MELLITUS, TYPE 1;
DRUG COSTS;
DRUG INDUSTRY;
DRUGS, ESSENTIAL;
DRUGS, GENERIC;
HEALTH SERVICES ACCESSIBILITY;
HUMANS;
HYPOGLYCEMIC AGENTS;
INSULIN;
EURASIA;
EUROPE;
UNITED KINGDOM;
WESTERN EUROPE;
|
EID: 48749108721
PISSN: 00429686
EISSN: 15640604
Source Type: Journal
DOI: 10.2471/BLT.07.048710 Document Type: Short Survey |
Times cited : (26)
|
References (7)
|